Likang Life Sciences says it has developed a personalised vaccine using advanced tech to identify tumour-specific mutations.

Likang Life Sciences says it has developed a personalised vaccine using advanced tech to identify tumour-specific mutations.

China is launching its first AI-assisted personalised tumour vaccine production line in Beijing, offering new hope for millions battling the nation's second-leading cause of death.